We are live on ! Find out more
DIM

DC Investments Management Portfolio holdings

AUM $261M
1-Year Est. Return 20.71%
This Fund
S&P 500
This Quarter Est. Return
+3.69%
1 Year Est. Return
+20.71%
3 Year Est. Return
+44.71%
5 Year Est. Return
+36.74%
10 Year Est. Return
–
AUM
$157M
AUM Growth
+$8.18M
Cap. Flow
+$6.12M
Cap. Flow %
3.89%
Top 10 Hldgs %
6.71%
Holding
424
New
174
Increased
42
Reduced
68
Closed
139

Top Buys

Rank Stock Value
1
EVRG icon
Evergy
EVRG
+$1.09M
2
AER icon
AerCap
AER
+$863K
3
GRMN
Garmin
GRMN
+$838K
4
GSK icon
GSK
GSK
+$820K
5
SF
Stifel
SF
+$818K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.51M
2
AMGN icon
Amgen
AMGN
+$2.11M
3
JNJ icon
Johnson & Johnson
JNJ
+$1.68M
4
NOC icon
Northrop Grumman
NOC
+$1.55M
5
BDX icon
Becton Dickinson
BDX
+$1.52M

Sector Composition

Rank Sector Weight
1 Healthcare 19.87%
2 Financials 19.67%
3 Technology 12.25%
4 Real Estate 10.82%
5 Utilities 10.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCH icon
301
Banco de Chile
BCH
$21.3B
– –
-12,057
Closed -$395K
BDX icon
302
Becton Dickinson
BDX
$48.8B
– –
-7,173
Closed -$1.52M
BFAM icon
303
Bright Horizons
BFAM
$3.89B
– –
-8,025
Closed -$800K
BMY icon
304
Bristol-Myers Squibb
BMY
$131B
– –
-4,853
Closed -$307K
BSAC icon
305
Banco Santander Chile
BSAC
$16.8B
– –
-12,196
Closed -$409K
BTI icon
306
British American Tobacco
BTI
$127B
– –
-4,988
Closed -$288K
BWB icon
307
Bridgewater Bancshares
BWB
$592M
– –
-31,274
Closed -$409K
CABO icon
308
Cable One
CABO
$252M
– –
-430
Closed -$295K
CAE icon
309
CAE Inc. Common Shares
CAE
$8.61B
– –
-18,185
Closed -$338K
CBOE icon
310
Cboe Global Markets
CBOE
$30.2B
– –
-3,234
Closed -$369K
CCU icon
311
Compañía de Cervecerías Unidas
CCU
$2.21B
– –
-9,084
Closed -$267K
CDLX icon
312
Cardlytics
CDLX
$20.4M
– –
-2,992
Closed -$438K
CHDN icon
313
Churchill Downs
CHDN
$6.06B
– –
-7,002
Closed -$285K
CI icon
314
Cigna
CI
$72.7B
– –
-1,479
Closed -$248K
CLX icon
315
Clorox
CLX
$12.8B
– –
-2,312
Closed -$308K
CMPR icon
316
Cimpress
CMPR
$2.34B
– –
-1,866
Closed -$289K
COGT icon
317
Cogent Biosciences
COGT
$7.14B
– –
-8,881
Closed -$395K
CP icon
318
Canadian Pacific Kansas City
CP
$79.3B
– –
-6,455
Closed -$228K
CRM icon
319
Salesforce
CRM
$153B
– –
-2,681
Closed -$312K
DBX icon
320
Dropbox
DBX
$8.06B
– –
-12,788
Closed -$400K
DHI icon
321
D.R. Horton
DHI
$40.8B
– –
-6,208
Closed -$272K
ECL icon
322
Ecolab
ECL
$79.8B
– –
-4,366
Closed -$598K
EIX icon
323
Edison International
EIX
$25.9B
– –
-12,870
Closed -$819K
EMR icon
324
Emerson Electric
EMR
$87.5B
– –
-4,181
Closed -$286K
ENIC icon
325
Enel Chile
ENIC
$6.32B
– –
-29,024
Closed -$186K
11 12
13
14 15

Similar funds

DC
Dayah Capital Stamford, Connecticut $261M AUM
AFC
Adaptive Financial Consulting Beachwood, Ohio $261M AUM 8.02% 1-Year Est. Return
TIG
Tribune Investment Group New York $261M AUM 70.13% 1-Year Est. Return
NG
NWK Group San Francisco, California $261M AUM 50.13% 1-Year Est. Return
ICM
Intrepid Capital Management Jacksonville Beach, Florida $261M AUM 20.02% 1-Year Est. Return
TSW
Three Seasons Wealth Salt Lake City, Utah $262M AUM 45.03% 1-Year Est. Return
ACM
Ananym Capital Management New York $262M AUM 22.94% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

DC Investments Management's Q2 2018 Portfolio in Review

As of Q2 2018, DC Investments Management held 424 positions worth $157M, up 5.5% from $149M the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.

DC Investments Management deployed $6.12M of net new capital in Q2 2018, opening 174 new positions and adding to 42 existing holdings. Its largest new stake was Evergy: 20,319 shares worth $1.14M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Pfizer, an estimated $2.51M trimmed.

  • DC Investments Management's largest Q2 2018 buy was Evergy: 20,319 shares worth $1.14M.
  • DC Investments Management added most to TotalEnergies in Q2 2018, an estimated $612K increase.
  • DC Investments Management's biggest Q2 2018 reduction was Pfizer, cutting an estimated $2.51M.
  • DC Investments Management fully exited Amgen in Q2 2018, selling an estimated $2.11M.
  • DC Investments Management's ten largest holdings make up 6.7% of its $157M portfolio in Q2 2018.
  • DC Investments Management opened 174 new positions and closed 139 in Q2 2018.
  • DC Investments Management's portfolio value rose 5.5% quarter-over-quarter to $157M.

Based on DC Investments Management's 13F filing for Q2 2018, filed 3 Aug 2018.